Abbott Laboratories

Abbott Laboratories

Yahoo Finance • 5 hours ago

Abbott hosts conference call for third-quarter earnings

ABBOTT PARK, Ill., Sept. 30, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2026 financial results on Wednesday, Oct. 21, before the market opens. The announcement will be followed by a live webcast of the earning... Full story

Yahoo Finance • 6 hours ago

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help eligible patients get screened1-3 SimpleScree... Full story

Yahoo Finance • 2 days ago

Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players

Company Logo Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while Asia-Pacific is expected to gro... Full story

Yahoo Finance • 3 days ago

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?

Gilead Sciences, Inc. (NASDAQ:GILD) and Abbott Laboratories (NYSE:ABT) both return cash to shareholders through dividends, but the businesses supporting those payouts look very different. Gilead is currently growing faster, powered by an... Full story

Yahoo Finance • 6 days ago

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery

Tributary Capital Management released its second-quarter 2026 investor letter for "Multi Cap Core Equity Strategy". You can download a copy of the letter here. The Tributary Multi Cap Core's equity allocation underperformed in Q2, returnin... Full story

Yahoo Finance • 6 days ago

TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher

Company Logo Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific. Dublin, Sept. 24, 2026 (GLOBE NEWSWI... Full story

Yahoo Finance • 7 days ago

Is Abbott’s Digital Health Push and Formula Settlement Altering The Investment Case For Abbott (ABT)?

In recent weeks, Abbott and Berry Street announced an exclusive partnership that combines Abbott's Lingo over-the-counter continuous glucose monitor with Berry Street's insurance-covered virtual nutrition coaching, while Abbott's Volt Puls... Full story

Yahoo Finance • 7 days ago

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker SYK entered 2026 facing an unexpected cyber disruption, yet underlying demand, robotics adoption and international momentum remained strong. While a robust capital pipeline and active acquisition strategy support long-term growth,... Full story

Yahoo Finance • 7 days ago

What Makes Abbott Laboratories (ABT) an Attractive Opportunity?

Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here. The fund highlighted a period of strong equity market gains as the S&P 500 surged ~17% following March's selloff, driven by resilient... Full story

Yahoo Finance • 7 days ago

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of... Full story

Yahoo Finance • 7 days ago

Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health

Partnership combines Abbott's Lingo continuous glucose monitor with Berry Street's insurance-covered registered dietitian support, helping consumers translate glucose insights into healthier behaviors Research shows registered dietitian-le... Full story

Yahoo Finance • 7 days ago

Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share

Company Logo Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "T... Full story

Yahoo Finance • 8 days ago

3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors

Dividend stocks can provide retirees with recurring cash flow that can help them accumulate income without having to deplete their nest eggs. What's important, however, is to also minimize risk and volatility, to ensure that retirees aren'... Full story

Yahoo Finance • 8 days ago

Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)

Reflecting On Therapeutics Stocks' Q2 Earnings: AbbVie (NYSE:ABBV) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at AbbVie (NYSE:ABBV) and its peers. Over the... Full story

Yahoo Finance • 9 days ago

3 Defensive Dividend Stocks For Steady Income as Fed Pressure Builds

Markets are wrestling with a Fed that sounds more willing to tolerate economic pain than investors expected, while supply shocks from oil and tariffs keep pressure on costs. That mix tends to push attention toward reliable cash flows and d... Full story

Yahoo Finance • 9 days ago

SMARTIES™ Vietnam Announces 2026 Shortlist, Celebrating 187 Standout Entries

HO CHI MINH CITY, Vietnam, Sept. 21, 2026 /PRNewswire/ -- SMARTIES™ Vietnam has officially announced its 2026 Shortlist, recognizing 187 entries that have distinguished themselves through this year's rigorous judging process and moved one... Full story

Yahoo Finance • 9 days ago

Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?

Boston Scientific BSX is preparing for a steady stream of product launches over the next two years that could become an important source of incremental growth. In Interventional Cardiology, the company plans to launch the SEISMIQ 4CE Coron... Full story

Yahoo Finance • 9 days ago

Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players

Company Logo Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. According to the research report, the global wearable biosensors market... Full story

Yahoo Finance • 12 days ago

Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031

Company Logo The global interventional cardiology devices market is forecast to grow from USD 31.12 billion in 2026 to USD 42.39 billion by 2031, at a 6.4% CAGR. Growth is driven by rising cardiovascular disease, aging populations, demand... Full story

Yahoo Finance • 13 days ago

Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

[Wall Street New York stock exchange stock market] alexsl Citi downgraded Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) to Neutral from Buy, saying that it is still contending with the aftermath of an August cyberattack [h... Full story